S. Aaltomaa et al., Expression of cyclin A and D proteins in prostate cancer and their relation to clinopathological variables and patient survival, PROSTATE, 38(3), 1999, pp. 175-182
BACKGROUND. Cell proliferation and its regulation are important determinant
s of the prognosis of prostate cancer patients. Cyclins are important regul
ators of cell proliferation in human cancer, but their prognostic value has
not been previously analyzed in prostate cancer.
METHODS. The immunohistochemical expression and prognostic value of cyclins
A and D were studied in prostate cancer in a cohort of 213 patients follow
ed-up for a mean of 12 years.
RESULTS. The expression of cyclin A was both cytoplasmic and nuclear, where
as the expression of cyclin D was nuclear. The mean (SD) fraction of cyclin
A- and cyclin D-positive cells was 2.1 (7.9)% and 16.3 (23.4)%, respective
ly. The expression of cyclin A was related to TM-category, histological dif
ferentiation, perineural invasion, S-phase fraction, and expression of Ki67
and bcl-2 (for all, P < 0.05). The expression of cyclin D was related to c
lassification, histological differentiation, perineural invasion, DNA ploid
y, S-phase fraction, expression of Ki67, and mitotic index (for all, P less
than or equal to 0.01). In survival analysis, expression of cyclin A predi
cted cancer-related survival in the entire cohort (P < 0.001). Expression o
f cyclin D predicted cancer-related survival in the entire cohort (P < 0.00
01), in MO (P = 0.0007), and in T1-2NxM0 tumors (P = 0.0003). in Cox multiv
ariate analysis, T-category, M-category, patient age, and the fraction of c
yclin A-positive cells were independent predictors of survival in the entir
e series. In local tumors, T-category, Gleason score, DNA ploidy, or S-phas
e fraction were independent prognostic factors, and cyclins had no independ
ent prognostic value.
CONCLUSIONS. The results show that the expression of cyclins A and D is rel
ated to several malignant cellular features in prostate cancer, but they ha
ve no independent prognostic value. (C) 1999 Wiley-Liss, Inc.